Ardelyx Inc [ARDX] stock is trading at $7.99, up 2.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ARDX shares have gain 13.49% over the last week, with a monthly amount glided 40.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ardelyx Inc [NASDAQ: ARDX] stock has seen the most recent analyst activity on January 09, 2026, when Piper Sandler upgraded its rating to a Overweight. Raymond James downgraded its rating to a Outperform but stick to its price target of $11 on May 02, 2025. BTIG Research started tracking with a Buy rating for this stock on March 04, 2025, and assigned it a price target of $14. In a note dated November 11, 2024, H.C. Wainwright downgraded an Neutral rating on this stock and revised its target price from $11 to $5.50.
Ardelyx Inc [ARDX] stock has fluctuated between $3.21 and $8.05 over the past year. Currently, Wall Street analysts expect the stock to reach $15.6 within the next 12 months. Ardelyx Inc [NASDAQ: ARDX] shares were valued at $7.99 at the most recent close of the market. An investor can expect a potential return of 95.24% based on the average ARDX price forecast.
Analyzing the ARDX fundamentals
Ardelyx Inc [NASDAQ:ARDX] reported sales of 398.23M for the trailing twelve months, which represents a growth of 12.30%. Gross Profit Margin for this corporation currently stands at 0.89% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.14%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.37 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Ardelyx Inc’s Current Ratio is 4.41. As well, the Quick Ratio is 4.11, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 4.87, the price to book ratio is 12.58.
Transactions by insiders
Recent insider trading involved Williams Laura A, Chief Patient Officer, that happened on Jan 08 ’26 when 50000.0 shares were sold. Officer, LAURA A WILLIAMS completed a deal on Jan 08 ’26 to buy 50000.0 shares. Meanwhile, GRAMMER ELIZABETH A sold 5995.0 shares on Nov 21 ’25.
